Malaysia

Salmaan H. Inayat-Hussain, Jamaludin Abu Bakar, Effendi Ibrahim, Mazlin Mokhtar, Michelle Alia Nunis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Malaysia's industries in the areas of medical devices, pharmaceuticals, herbal medicine, nutraceuticals, and cosmeceuticals are rapidly growing. Therefore, there is an increasing urgency for the toxicological safety assessment of these products. Some regulations are already in place in the country and certain regulations concerning toxicity testing are currently being discussed for mandatory adoption by the industries. As an example, in Malaysia the standard that has been accepted by the Industry Standard Committee on Medical Devices (ISC-R) was MS ISO 10993-3:2005, Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Other parts of the ISO 10993-3 biological evaluation of medical devices are currently being discussed for adoption to meet the goals of the Malaysia Medical Devices Act 2007. The herbal industry is an important sector in the country where products developed include cosmetics, health foods and herbal pharmaceuticals. Universities and research institutions have been performing various types of toxicity testing and currently a committee at the Institute for Medical Research of the Ministry of Health is coordinating a global information hub on integrated medicine. In this committee, issues including the regulation of safety of herbal products are being discussed.

Original languageEnglish
Title of host publicationInformation Resources in Toxicology
PublisherElsevier Inc.
Pages1013-1022
Number of pages10
ISBN (Print)9780123735935
DOIs
Publication statusPublished - 2009

Fingerprint

Malaysia
Industry
Equipment and Supplies
Carcinogenicity Tests
Mutagenicity Tests
Safety
Herbal Medicine
Health
Dietary Supplements
Developed Countries
Cosmetics
Pharmaceutical Preparations
Toxicology
Biomedical Research
Medicine
Food
Research

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Inayat-Hussain, S. H., Abu Bakar, J., Ibrahim, E., Mokhtar, M., & Alia Nunis, M. (2009). Malaysia. In Information Resources in Toxicology (pp. 1013-1022). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-373593-5.00096-3

Malaysia. / Inayat-Hussain, Salmaan H.; Abu Bakar, Jamaludin; Ibrahim, Effendi; Mokhtar, Mazlin; Alia Nunis, Michelle.

Information Resources in Toxicology. Elsevier Inc., 2009. p. 1013-1022.

Research output: Chapter in Book/Report/Conference proceedingChapter

Inayat-Hussain, SH, Abu Bakar, J, Ibrahim, E, Mokhtar, M & Alia Nunis, M 2009, Malaysia. in Information Resources in Toxicology. Elsevier Inc., pp. 1013-1022. https://doi.org/10.1016/B978-0-12-373593-5.00096-3
Inayat-Hussain SH, Abu Bakar J, Ibrahim E, Mokhtar M, Alia Nunis M. Malaysia. In Information Resources in Toxicology. Elsevier Inc. 2009. p. 1013-1022 https://doi.org/10.1016/B978-0-12-373593-5.00096-3
Inayat-Hussain, Salmaan H. ; Abu Bakar, Jamaludin ; Ibrahim, Effendi ; Mokhtar, Mazlin ; Alia Nunis, Michelle. / Malaysia. Information Resources in Toxicology. Elsevier Inc., 2009. pp. 1013-1022
@inbook{cd81f4d3dc0b467e96231e265778a0e9,
title = "Malaysia",
abstract = "Malaysia's industries in the areas of medical devices, pharmaceuticals, herbal medicine, nutraceuticals, and cosmeceuticals are rapidly growing. Therefore, there is an increasing urgency for the toxicological safety assessment of these products. Some regulations are already in place in the country and certain regulations concerning toxicity testing are currently being discussed for mandatory adoption by the industries. As an example, in Malaysia the standard that has been accepted by the Industry Standard Committee on Medical Devices (ISC-R) was MS ISO 10993-3:2005, Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Other parts of the ISO 10993-3 biological evaluation of medical devices are currently being discussed for adoption to meet the goals of the Malaysia Medical Devices Act 2007. The herbal industry is an important sector in the country where products developed include cosmetics, health foods and herbal pharmaceuticals. Universities and research institutions have been performing various types of toxicity testing and currently a committee at the Institute for Medical Research of the Ministry of Health is coordinating a global information hub on integrated medicine. In this committee, issues including the regulation of safety of herbal products are being discussed.",
author = "Inayat-Hussain, {Salmaan H.} and {Abu Bakar}, Jamaludin and Effendi Ibrahim and Mazlin Mokhtar and {Alia Nunis}, Michelle",
year = "2009",
doi = "10.1016/B978-0-12-373593-5.00096-3",
language = "English",
isbn = "9780123735935",
pages = "1013--1022",
booktitle = "Information Resources in Toxicology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Malaysia

AU - Inayat-Hussain, Salmaan H.

AU - Abu Bakar, Jamaludin

AU - Ibrahim, Effendi

AU - Mokhtar, Mazlin

AU - Alia Nunis, Michelle

PY - 2009

Y1 - 2009

N2 - Malaysia's industries in the areas of medical devices, pharmaceuticals, herbal medicine, nutraceuticals, and cosmeceuticals are rapidly growing. Therefore, there is an increasing urgency for the toxicological safety assessment of these products. Some regulations are already in place in the country and certain regulations concerning toxicity testing are currently being discussed for mandatory adoption by the industries. As an example, in Malaysia the standard that has been accepted by the Industry Standard Committee on Medical Devices (ISC-R) was MS ISO 10993-3:2005, Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Other parts of the ISO 10993-3 biological evaluation of medical devices are currently being discussed for adoption to meet the goals of the Malaysia Medical Devices Act 2007. The herbal industry is an important sector in the country where products developed include cosmetics, health foods and herbal pharmaceuticals. Universities and research institutions have been performing various types of toxicity testing and currently a committee at the Institute for Medical Research of the Ministry of Health is coordinating a global information hub on integrated medicine. In this committee, issues including the regulation of safety of herbal products are being discussed.

AB - Malaysia's industries in the areas of medical devices, pharmaceuticals, herbal medicine, nutraceuticals, and cosmeceuticals are rapidly growing. Therefore, there is an increasing urgency for the toxicological safety assessment of these products. Some regulations are already in place in the country and certain regulations concerning toxicity testing are currently being discussed for mandatory adoption by the industries. As an example, in Malaysia the standard that has been accepted by the Industry Standard Committee on Medical Devices (ISC-R) was MS ISO 10993-3:2005, Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Other parts of the ISO 10993-3 biological evaluation of medical devices are currently being discussed for adoption to meet the goals of the Malaysia Medical Devices Act 2007. The herbal industry is an important sector in the country where products developed include cosmetics, health foods and herbal pharmaceuticals. Universities and research institutions have been performing various types of toxicity testing and currently a committee at the Institute for Medical Research of the Ministry of Health is coordinating a global information hub on integrated medicine. In this committee, issues including the regulation of safety of herbal products are being discussed.

UR - http://www.scopus.com/inward/record.url?scp=84882837535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882837535&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-373593-5.00096-3

DO - 10.1016/B978-0-12-373593-5.00096-3

M3 - Chapter

AN - SCOPUS:84882837535

SN - 9780123735935

SP - 1013

EP - 1022

BT - Information Resources in Toxicology

PB - Elsevier Inc.

ER -